The UK’s largest drugmaker, AstraZeneca (LSE: AZN), has announced the launch of a new artificial intelligence (AI)-focused digital health solutions company, to be called Evinova.
The company will aim to bring to market certain established and scaled digital technology solutions which are already being used by AstraZeneca in the course of its clinical trial design and delivery work. These are designed to reduce the time and cost of developing…
